Kathy Fiekert holds a Master of Science in the Control of Infectious Diseases from the London School of Hygiene and Tropical Medicine, and has over 30 years of experience in public health, infectious disease control programmes and operational research in low- and lower middle income countries (mainly in complex emergency situations).
As a Senior TB Consultant, Kathy has significant experience advising national and local government bodies, NGOs and the donor sector. Kathy’s work links community engagement, people-centred approaches, ethics, and human rights to strengthening resilient and sustainable systems for health, joint strategic planning, and design innovative approaches to TB care utilising digital health technologies.
Kathy has published extensively and currently serves on several global policy advisory bodies, including the Global Fund Technical Review Panel, WHO Guideline Development Groups, and as a member of the TB Modelling and Analysis Consortium Steering Committee.
Within KNCV, Kathy leads the Health and Community Systems team, and coordinates the People-Centred Framework for TB Programming Approach, and Stigma Reduction & Social Protection Initiatives. Kathy also provides technical support to country and NGO TB programmes on situation and gap analyses, programme design and evaluation, strategic planning, resilient and sustainable systems for health, and management capacity development.
Recent publications
- Spruijt I, Nazir M, Villanueva A, Jansen N, Huitema I, Fiekert K. Respected but stigmatized: Healthcare workers caring for COVID-19 patients. PLoS One 2023.
- Dodd PJ, McQuaid CF, Rao P, Abubakar I, Arinaminpathy N, Fiekert K et al. Improving the quality of the Global Burden of Disease tuberculosis estimates from the Institute for Health Metrics and Evaluation. Int J Epidemiol. 2023.
- McQuaid, C. F., A. Vassall, T. Cohen, Fiekert COVID/TB Modelling Working Group and R. G. White (2021). “The impact of COVID-19 on TB: a review of the data.” International Journal of TB and Lung Diseases 25(6): 436-446.
- Gronholm, P. C., M. Nose, W. H. van Brakel, J. Eaton, B. Ebenso, Fiekert, F. Hanna, M. Milenova, C. Sunkel, C. Barbui and G. Thornicroft (2021). “Reducing stigma and discrimination associated with COVID-19: early-stage pandemic rapid review and practical recommendations.” Epidemiology and Psychiatric Sciences 30(E15).25.
- Spruijt, I., D. T. Haile, S. van den Hof, Fiekert, N. Jansen, D. Jerene, E. Klinkenberg, I. Leimane and J. Suurmond (2020). “Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection: a qualitative study among Eritreans in the Netherlands.” BMC Public Health 20(1).
- Denholm, J. T., J. C. Millan-Marcelo and Fiekert (2020). “Latent tuberculosis infection and the EndTB Strategy: ethical tensions and imperatives.” The International Journal of Tuberculosis and Lung Disease 24(5): 21-26.
- van Oosterhout, D., C. Negri, A. Bedru, Fiekert, I. Leimane and S. Boorsboom (2019). Targeted interventions to improve TB services while addressing stigma related issues, Ethiopia. The Hague KNCV Tuberculosis Foundation/ Challenge TB.
read all the KNCV publications